Erratum: Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)

D. Bourdette, D. Hartung

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1537
Number of pages1
JournalJAMA Neurology
Issue number12
StatePublished - Dec 2015

ASJC Scopus subject areas

  • Clinical Neurology

Cite this